Inhibition of immune responses by ITAM-bearing receptors. - sprookjes - yvandenbroek - TriplyDB

Inhibition of immune responses by ITAM-bearing receptors.

Inhibition of immune responses by ITAM-bearing receptors.

http://www.wikidata.org/entity/Q36383231

about

High affinity soluble ILT2 receptor: a potent inhibitor of CD8(+) T cell activation Dendritic cell-bound IgE functions to restrain allergic inflammation at mucosal sites The tyrosine kinase Syk differentially regulates Toll-like receptor signaling downstream of the adaptor molecules TRAF6 and TRAF3 Plasmacytoid dendritic cells, interferon signaling, and FcγR contribute to pathogenesis and therapeutic response in childhood immune thrombocytopenia.Indirect inhibition of Toll-like receptor and type I interferon responses by ITAM-coupled receptors and integrins.DAP12 is required for macrophage recruitment to the lung in response to cigarette smoke and chemotaxis toward CCL2 Shifting FcγRIIA-ITAM from activation to inhibitory configuration ameliorates arthritis CEACAM2 negatively regulates hemi (ITAM-bearing) GPVI and CLEC-2 pathways and thrombus growth in vitro and in vivo.ITAM signaling in dendritic cells controls T helper cell priming by regulating MHC class II recycling.Proteomic analysis of lymphoblastoid cells from Nasu-Hakola patients: a step forward in our understanding of this neurodegenerative disorder.Expression of the B-cell receptor component CD79a on immature myeloid cells contributes to their tumor promoting effects Diminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type I interferons The immunoreceptor adapter protein DAP12 suppresses B lymphocyte-driven adaptive immune responses.Role of chaperones and FcgammaR in immunogenic death.The expanding roles of ITAM adapters FcRgamma and DAP12 in myeloid cells.Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity.Siglec-H protects from virus-triggered severe systemic autoimmunity.Structural characteristics of zebrafish orthologs of adaptor molecules that associate with transmembrane immune receptors.A novel phage element of Salmonella enterica serovar Enteritidis P125109 contributes to accelerated type III secretion system 2-dependent early inflammation kinetics in a mouse colitis model Negative regulation of osteoclast precursor differentiation by CD11b and β2 integrin-B-cell lymphoma 6 signaling Activation, coactivation, and costimulation of resting human natural killer cells Increased TLR responses in dendritic cells lacking the ITAM-containing adapters DAP12 and FcRgamma.DAP12 Inhibits Pulmonary Immune Responses to Cryptococcus neoformans Immunosupportive therapies in aging.LILRA2 activation inhibits dendritic cell differentiation and antigen presentation to T cells.Deletion of activating Fcgamma receptors does not confer protection in murine cryoglobulinemia-associated membranoproliferative glomerulonephritis A signal-switch hypothesis for cross-regulation of cytokine and TLR signalling pathways.DAP10- and DAP12-associated receptors in innate immunity.Cross-regulation of signaling by ITAM-associated receptors.Multiple roles of Lyn kinase in myeloid cell signaling and function.Leukocyte Ig-like receptor B4 (LILRB4) is a potent inhibitor of FcgammaRI-mediated monocyte activation via dephosphorylation of multiple kinases Heterogeneity of microglial activation in the innate immune response in the brain.Host Immune Responses in HIV-1 Infection: The Emerging Pathogenic Role of Siglecs and Their Clinical Correlates.Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond.Regulation of TLR7/9 signaling in plasmacytoid dendritic cells.CMV-encoded Fcγ receptors: modulators at the interface of innate and adaptive immunity.Lyn and Fyn function as molecular switches that control immunoreceptors to direct homeostasis or inflammation TREM2-Ligand Interactions in Health and Disease.Impact of Glycosylation on Effector Functions of Therapeutic IgG Cross Talk between Inhibitory Immunoreceptor Tyrosine-Based Activation Motif-Signaling and Toll-Like Receptor Pathways in Macrophages and Dendritic Cells.

P2860

Q24324563-1EFF3B0E-C13C-4CE0-B477-CD5E7DE9F97B Q28390013-F7CF6275-A1EE-42CE-BC11-ABDBFB0E0A4D Q28590988-32069DCA-ABEF-4BDB-9BCB-C4BF40472A4C Q33409032-214EA38C-5C9C-4124-838A-A3EF601FEC08 Q33822008-DF46875F-DB63-4506-B664-B1356EF396EB Q33881316-D5112D3C-5C81-416E-9CC3-9D2964359BBF Q34117596-6CAA6666-1F17-472F-A55D-D04033CE8CC4 Q34318501-5DCE4C07-E490-42B6-B5E2-A8A934BFACAE Q34369816-95A5263D-8019-4D3B-AA66-DBCD7CD3B6D6 Q34623948-9F1CE540-35E9-4009-BBF8-5816B9F4763D Q35022631-1E10432C-03DE-4C4F-B16D-96820BCD3322 Q35140055-3086EF5C-5334-40EE-9EDC-63C93940642D Q35144618-CBAEC1CF-6FA6-4A39-A3F8-CE2AC122A06C Q35575030-B5FF7756-3924-4256-840C-438B0A03E360 Q35640941-D7F2C7BC-1E56-463B-8D71-AE4A00314530 Q35909663-0D24088A-4BF9-41C1-81EE-BD46BD19A731 Q36067728-0C8EF93B-991A-4482-8B92-076E2667A067 Q36103381-7FAF6C9B-BE64-4C64-B613-E3CD5717D453 Q36163160-27A47967-6CF6-41F9-BCC4-D7BE4FA3FB12 Q36468037-C43B3B13-EDEF-4521-BD5B-51DAEDFF21EF Q36652166-0D8DC730-6C12-4545-B941-3521889EE01E Q36982907-A81774D5-61F0-4AFE-ADE6-4AFD6D4979D6 Q37002280-C2D395AC-6C15-4E62-AB0C-FD9F9C9CC91C Q37017265-3443F86D-E758-46AD-925B-86E816695D0A Q37116235-33644741-1D21-45E6-AFA2-555652C5C7A4 Q37257130-3BCC657C-9FDB-45C8-9EE3-4BEEAF4DF63D Q37267214-0D93BA98-72AF-4A7D-8447-4C28D4854897 Q37361459-E38CD6BC-0D82-40B2-9FA9-FC668183FCCD Q37366524-25D39E3A-2318-4608-8FA0-A89FB2C1BF0D Q37416257-7761297E-ABD5-49C7-91D0-57B07FAE56F8 Q37454255-51531478-FE5B-4F5E-ADE4-BB053DA86D79 Q37572598-BB6AC99F-291A-4890-AB0F-2FB3C7A3B178 Q37716750-846F7472-C181-4C2E-A2FB-DB3E1BAF64F1 Q37998314-B54DF467-ABFA-447B-A574-67176D23039A Q38058240-58471A04-311D-499A-B79A-876451765613 Q38257496-A7D0D2E0-828C-4C4C-92DF-3C2E9B3F065F Q38623017-716F0B23-8AB0-45DF-A22F-BE7874C87235 Q38692159-7C758749-E163-406C-9C1D-86E257165ED1 Q38818688-4EECBE37-4B97-4460-BC91-24ECD6BE94C7 Q39260017-FE3F5523-3A4C-4CF6-AAA6-FDA510A6B21B

P2860

Inhibition of immune responses by ITAM-bearing receptors.

http://www.wikidata.org/entity/Q36383231

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Inhibition of immune responses by ITAM-bearing receptors.

@ast

Inhibition of immune responses by ITAM-bearing receptors.

@en

type

label

Inhibition of immune responses by ITAM-bearing receptors.

@ast

Inhibition of immune responses by ITAM-bearing receptors.

@en

prefLabel

Inhibition of immune responses by ITAM-bearing receptors.

@ast

Inhibition of immune responses by ITAM-bearing receptors.

@en

P1433

Q36383231-D4C37831-2BAD-42E9-97DF-8C8B489BF80C

P1476

Q36383231-9183C3AC-CB1A-4417-B78C-2944EAEB59DE

P2093

Q36383231-562A13B4-8957-4D8D-B049-F036E8763FDB

Q36383231-EF1E1386-5E6C-434B-BEA8-1EB041B3BDE1

P2860

Q36383231-01CC118F-4C7F-4750-8A6C-F1BBC12E5A9F

Q36383231-03FE506D-7464-4BB9-8F07-CECD78325D85

Q36383231-0A07EEB8-F27E-4CB6-BDD3-82468A6146B2

Q36383231-16F6E7B8-17DC-4F02-871F-BC5517A6ED9E

Q36383231-25EC0650-3044-4658-9870-D7D803D60ED8

Q36383231-2F73A40C-3F80-435B-BF87-DA416CA2EAB7

Q36383231-300B965D-7D92-44C9-B0D9-338F261C60ED

Q36383231-32602A1A-1E81-4630-8A51-1C1CCD01C19D

Q36383231-3923D919-590F-4059-B778-E935861DB0DA

Q36383231-3B7900FD-772F-40A3-B49F-77906822B044

P304

Q36383231-AA52275B-54A5-4CB0-B2E1-CDF4BAB64505

P31

Q36383231-F35704FF-0797-4917-8F9E-4400B9D93DFC

P356

Q36383231-25F5BCB8-F54B-4477-9498-B99C5A4F20BC

P433

Q36383231-41927C5A-1534-402A-98B5-F7CA9E24CD03

P478

Q36383231-734203C2-E325-43BB-89F2-6BAC8552B907

P577

Q36383231-A591CF5B-3995-4F5F-8825-1F3E4F8C3029

P698

Q36383231-7A56B2B1-C00B-4232-8C49-A9F2215E5829

P356

STKE.3202006RE1

P1433

Science's STKE : signal transduction knowledge environment

P1476

Inhibition of immune responses by ITAM-bearing receptors.

@en

P2093

Jessica A Hamerman

http://www.w3.org/2001/XMLSchema#string

Lewis L Lanier

http://www.w3.org/2001/XMLSchema#string

P2860

Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice

Interference with immunoglobulin (Ig)alpha immunoreceptor tyrosine-based activation motif (ITAM) phosphorylation modulates or blocks B cell development, depending on the availability of an Igbeta cytoplasmic tail

TREM-1 amplifies inflammation and is a crucial mediator of septic shock

Mast cell signal transduction from the high-affinity IgE receptor

IgA Fc receptors

Paired activating and inhibitory immunoglobulin-like receptors, MAIR-I and MAIR-II, regulate mast cell and macrophage activation

Negative regulation of natural killer cell function by EAT-2, a SAP-related adaptor

FcgammaRIV: a novel FcR with distinct IgG subclass specificity

NKp44 triggers NK cell activation through DAP12 association that is not influenced by a putative cytoplasmic inhibitory sequence

IgG Fc receptors

P304

re1

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/STKE.3202006RE1

http://www.w3.org/2001/XMLSchema#string

P433

320

http://www.w3.org/2001/XMLSchema#string

P478

2006

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16449667

http://www.w3.org/2001/XMLSchema#string